Trial Profile
Efficiency of Oseltamivir (Tamiflu) with Azithromycin Sustained Release (Zithromac SR) for inflammation.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Sep 2012
Price :
$35
*
At a glance
- Drugs Azithromycin (Primary) ; Oseltamivir (Primary)
- Indications Influenza A virus H1N1 subtype; Influenza A virus infections
- Focus Biomarker; Pharmacodynamics
- 23 Jul 2011 Actual end date (Apr 2011) as reported by University Hospital Medical Information Network - Japan
- 23 Jul 2011 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan
- 06 Apr 2011 New trial record